Sentiv
sentivcapital
$FSDC (thread): Merger with Gemini in January. Focused on huge GA/dAMD market (think multiples of wAMD). No current Tx, $APLS C3 first to market, with other C inhibitors to follow
Read more
$ARPO Thread: Raz P2b glaucoma readout Dec 15 to Jan 15, assigning 90% POS, potential 3 to 5x, with (likely) partnership 1H21. Glaucoma dead for Big Pharma unless there’s a
Read more
By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.